Belvedere Trading LLC Grifols Sa Put Options Transaction History

Belvedere Trading LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Nov 01, 2024	BUY	$6.27 - $7.7 $150,480 - $184,800	24,000 New	24,000 $151,000
Q2 2024 Aug 09, 2024	SELL	$6.27 - $7.7 $9,405 - $11,550	-1,500 Reduced 5.88%	24,000 $151,000
Q1 2024 May 09, 2024	BUY	$5.47 - $11.38 $139,485 - $290,190	25,500 New	25,500 $170,000
Q2 2023 Aug 08, 2023	BUY	$7.14 - $9.29 $7,140 - $9,290	1,000 New	1,000 $9,000

162

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.91B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.